Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Dennis Podlesak currently holds 210,963 shares of Alliqua BioMedical, Inc. (ADYX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dennis Podlesak has been a net seller of ADYX stock. They have purchased $207.0K and sold $2.8M worth of shares.
Dennis Podlesak's most recent insider trade was on Aug 18, 2025, when they sold 19,200 shares at $7.20 per share.
Dennis Podlesak serves as Executive at Alliqua BioMedical, Inc. (ADYX). They have executed 32 insider transactions totaling $3.0M over their tenure at the company.
Dennis Podlesak holds the position of Executive at Alliqua BioMedical, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Dennis Podlesak has shown a selling trading pattern, with $207.0K in total purchases and $2.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Dennis Podlesak was on Sep 15, 2022, when they sold $1.6M worth of SNDX shares. This transaction involved 66,840 shares at $24.20 per share.
Dennis Podlesak currently owns 210,963 shares of Alliqua BioMedical, Inc. (ADYX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Dennis Podlesak's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Dennis Podlesak has 32 Form 4 filings on record as an insider at Alliqua BioMedical, Inc..
Set alerts for Dennis Podlesak and 40,000+ other insiders.